Trump Announces Weight-Loss Drug Deal With Pharma in WH Event Marked by Scary Medical Issue
This post was originally published on here Donald Trump announced Thursday in the Oval Office that he’s struck a deal with two major pharmaceutical companies, Eli Lilly and Novo Nordisk, to lower prices for their popular weight-loss drugs, a new generation of products known as GLP-1 receptor agonists. The drugs, including Ozempic and Mounjaro, have…




